Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP[V717I] transgenic mice, a model for Alzheimer's disease
暂无分享,去创建一个
A Van der Linden | G. Vanhoutte | A. Van der Linden | F. van Leuven | I. Dewachter | P. Borghgraef | F Van Leuven | I Dewachter | G Vanhoutte | P Borghgraef
[1] G. Chiro,et al. T1 and t2 of ferritin at different field strengths: effect on mri , 1992, Magnetic resonance in medicine.
[2] K. Duff,et al. Quantitative histological analysis of amyloid deposition in Alzheimer’s double transgenic mouse brain , 2000, Neuroscience.
[3] S. Bondy,et al. Promotion of transition metal-induced reactive oxygen species formation by β-amyloid , 1998, Brain Research.
[4] W. Markesbery,et al. Oxidative Alterations in Alzheimer's Disease , 1999, Brain pathology.
[5] J. Hardy,et al. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1 , 1996, Nature.
[6] S. Younkin,et al. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. , 1994, Science.
[7] Koji Abe,et al. Amyloid cored plaques in Tg2576 transgenic mice are characterized by giant plaques, slightly activated microglia, and the lack of paired helical filament-typed, dystrophic neurites , 2002, Virchows Archiv.
[8] C. Masters,et al. Overexpression of Alzheimer's Disease Amyloid-β Opposes the Age-dependent Elevations of Brain Copper and Iron* , 2002, The Journal of Biological Chemistry.
[9] Susumu Mori,et al. Detection of amyloid plaques in mouse models of Alzheimer's disease by magnetic resonance imaging , 2004, Magnetic resonance in medicine.
[10] Russell E Jacobs,et al. Magnetic resonance microscopy of iron in the basal forebrain cholinergic structures of the aged mouse lemur , 1999, Journal of the Neurological Sciences.
[11] P. Mantyh,et al. Aluminum, Iron, and Zinc Ions Promote Aggregation of Physiological Concentrations of β‐Amyloid Peptide , 1993, Journal of neurochemistry.
[12] G. Schellenberg,et al. Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease , 1996, Nature Medicine.
[13] Z. Qian,et al. Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders , 1998, Brain Research Reviews.
[14] Mark A. Smith,et al. Iron: A Pathological Mediator of Alzheimer Disease? , 2002, Developmental Neuroscience.
[15] J. Treanor,et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.
[16] J. Trojanowski,et al. In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease , 2000, Neurobiology of Aging.
[17] I. Tesseur,et al. Modelling Alzheimer's disease in multiple transgenic mice. , 2001, Biochemical Society symposium.
[18] D. Feinstein,et al. A 27‐bp region of the inducible nitric oxide synthase promoter regulates expression in glial cells , 2001, Journal of neurochemistry.
[19] Thomas Wisniewski,et al. Molecular Targeting of Alzheimer's Amyloid Plaques for Contrast-Enhanced Magnetic Resonance Imaging , 2002, Neurobiology of Disease.
[20] G. Zubenko,et al. Clinically-Silent Mutation in the Putative Iron-Responsive Element in Exon 17 of the β-Amyloid Precursor Protein Gene , 1992, Journal of neuropathology and experimental neurology.
[21] I. Tesseur,et al. Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons , 2000, Neurobiology of Aging.
[22] M. Staufenbiel,et al. Cerebral Hemorrhage After Passive Anti-Aβ Immunotherapy , 2002, Science.
[23] A J Barkovich,et al. Normal deposition of brain iron in childhood and adolescence: MR imaging at 1.5 T. , 1989, Radiology.
[24] Marc Dhenain,et al. Senile plaques do not induce susceptibility effects in T 2*‐weighted MR microscopic images , 2002, NMR in biomedicine.
[25] J. Hardy,et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. , 1996, Nature medicine.
[26] Thomas Wisniewski,et al. Magnetic Resonance in Medicine 51:794–798 (2004) MRI Assessment of Neuropathology in a Transgenic Mouse Model of Alzheimer’s Disease , 2022 .
[27] G A Johnson,et al. Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[28] Veerle Baekelandt,et al. Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain* , 1999, The Journal of Biological Chemistry.
[29] J. Richardson,et al. Brain samples from Alzheimer's patients have elevated levels of loosely bound iron. , 1996, The International journal of neuroscience.
[30] W. Klein,et al. Iron Levels Modulate α‐Secretase Cleavage of Amyloid Precursor Protein , 1995, Journal of neurochemistry.
[31] N. Gelman,et al. Interregional variation of longitudinal relaxation rates in human brain at 3.0 T: Relation to estimated iron and water contents , 2001, Magnetic resonance in medicine.
[32] F. Leuven,et al. Axonal transport, tau protein, and neurodegeneration in Alzheimer’s disease , 2002, NeuroMolecular Medicine.
[33] B. Gelman,et al. Iron in CNS Disease , 1995, Journal of neuropathology and experimental neurology.
[34] M. Staufenbiel,et al. Cerebral hemorrhage after passive anti-Abeta immunotherapy. , 2002, Science.
[35] S. Younkin,et al. Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. , 1993, Science.
[36] C. Duyckaerts,et al. Cerebral T2-Weighted Signal Decrease During Aging in the Mouse Lemur Primate Reflects Iron Accumulation , 1998, Neurobiology of Aging.
[37] P. Hof,et al. The iron-binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis , 1994, Brain Research.
[38] Thomas Wisniewski,et al. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging , 2003, Magnetic resonance in medicine.
[39] C. Morris,et al. Non-haem iron histochemistry of the normal and Alzheimer's disease hippocampus. , 1994, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.